Please provide your email address to receive an email when new articles are posted on . Taking beta blockers may raise mortality risk for HSCT recipients due to suppression of signals from nerves that ...

NEW YORK, NY (April 27, 2022)--Roughly a third of all drugs approved by the U.S. Food and Drug Administration target a large family of biomolecules, known as G protein-coupled receptors (GPCRs), whose ...

Researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The study found phenylacetylglutamine (PAG), produced by gut bacteria ...

A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected. That’s the conclusion of a research team led by ...

This is a preview. Log in through your library . Abstract Nerves closely associate with blood vessels and help to pattern the vasculature during development. Recent work suggests that newly formed ...

In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington’s disease (HD) and the rate of worsening among ...

“This elegant study provides a possible pathway to explain the interaction between Aβ and hyperphosphorylated tau in the pathogenesis and progression of Alzheimer’s disease,” commented Lea Grinberg of ...

Dietz Researchers studied how chronic cocaine use changes neurobiological functions in the brain, in hopes to identify possible pharmaceutical therapies to combat addiction. Cocaine abuse and ...

Centhaquine (Lyfaquin ®) is an adrenergic agent that increases cardiac preload by activating alpha2B adrenergic receptors to increase venous blood return to the heart and decreases cardiac afterload ...